# Table 4 Results for secondary outcome measures

Analysis n= Movement Biofeedback Movement Biofeedback End of treatment period
Group effect # Group by time effect # Mean (SD)
Beta coefficient (95 % CI)
Beta coefficient (per 10 days in the treatment period) (95 % CI)
Daily pain score Sites = 8 −0.62 (−1.25 to 0.01) −0.051 (−0.075 to −0.026) Movement Biofeedback Group
(0 to 10 scale) Clinicians = 8
Participants = 98 p = 0.053 p < 0.001
Assessments = 6,036 4.26 (3.44 to 4.99)
Guidelines-based Care Group4.54 (3.88 to 5.19)
LBP recurrence (difference in proportions of days with reported recurrence) Sites = 8 −0.018 (−0.129 to 0.093) 0.003 (−0.002 to 0.008) Movement Biofeedback Group
Clinicians = 8
Participants = 100 p = 0.752 p = 0.263
Assessments = 5,999 0.230 (0.098 to 0.362)
Guidelines-based Care Group
0.173 (0.070 to 0.276)
Analgesic use Sites = 8 0.056 (−0.099 to 0.211) −0.007 (−0.013 to −0.002) Movement Biofeedback Group
(difference in proportion of days with reported taking of analgesics) Clinicians = 8
Participants = 98 p = 0.483 p = 0.008 0.288 (0.137 to 0.440)
Assessments = 5,815
Guidelines-based Care Group
0.360 (0.109 to 0.612)
Number of pain and Sites = 8 0.054 (0.003 to 0.107) 0.004 (0.002 to 0.007) Movement Biofeedback Group
medication free days Clinicians = 8    0.064 (−0.034 to 0.163)
Guidelines-based Care Group
0.036 (−0.006 to 0.077)
1. #The main effect of group indicates the average difference between the groups across treatment and outcome time points. The time-by-group interaction effect indicates the average difference between the groups in the rate of change over time. Both calculated by use of multilevel mixed-effects linear regression adjusted for baseline value of the outcome measure, age, gender, and duration of back pain episode (fixed effects) and treatment site, clinician and individual patient (random effects)
2. FABQpa = Fear Avoidance Beliefs Questionnaire (physical activity subscale) where low scores are better
3. Statistically significant p-values are bolded